GALECTIN THERAPEUTICS
Galectin Therapeutics is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Companyโs unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function. Galectin Therapeutics uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. Using these unique carbohydrate-ba... sed candidate compounds that bind and inhibit galectin proteins, we are pursuing therapies for indications where galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life threatening consequences to patients, and those where current treatment options are limited. Our strategy is to establish clinical development approaches that add value to the Company in the shortest time possible, and to seek partners as the program advances and requires much greater resources. Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer immunotherapy. Galectin Therapeutic stock is traded on the NASDAQ under the symbol GALT. The company is located in a suburb of Atlanta known as Norcross, Georgia USA
GALECTIN THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2000-12-01
Address:
Norcross, Georgia, United States
Country:
United States
Website Url:
http://www.galectintherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(678) 620-3186
Email Addresses:
[email protected]
Total Funding:
98.54 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Richard E Uihlein
Richard E Uihlein investment in Post-IPO Debt - Galectin Therapeutics
Richard E Uihlein
Richard E Uihlein investment in Post-IPO Debt - Galectin Therapeutics
Richard E Uihlein
Richard E Uihlein investment in Post-IPO Debt - Galectin Therapeutics
Richard E Uihlein
Richard E Uihlein investment in Post-IPO Debt - Galectin Therapeutics
10X Fund LP
10X Fund LP investment in Series B - Galectin Therapeutics
10X Fund LP
10X Fund LP investment in Series B - Galectin Therapeutics
10X Fund LP
10X Fund LP investment in Series B - Galectin Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Galectin Therapeutics
10X Fund LP
10X Fund LP investment in Series B - Galectin Therapeutics
10X Fund LP
10X Fund LP investment in Series B - Galectin Therapeutics
Official Site Inspections
http://www.galectintherapeutics.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago